Advertisement
Advertisement
IXHL
Incannex Healthcare Limited Common Stock
2.24
USDSponsored
-0.03
-1.32%
Nov 06, 15:59 UTC -5
Closed
After-Market
2.29
+0.04
+2.01%
Incannex Healthcare Limited Common Stock (IXHL) Earnings
IXHL Earnings Reports
Positive Surprise Ratio
IXHL beat 1 of 8 last estimates.
13%
Next Report
Next Week
Date of Next Report
Nov 12, 2026
Estimate for Q1 27 (Revenue/ EPS)
--
/-$0.49
Implied change from Q4 26 (Revenue/ EPS)
--
/-90.06%
Implied change from Q1 26 (Revenue/ EPS)
--
/-97.86%
Incannex Healthcare Limited Common Stock earnings per share and revenue
On Sep 25, 2026, IXHL reported earnings of -4.93 USD per share (EPS) for Q4 26, missing the estimate of -0.76 USD, resulting in a -547.51% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.35% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 3 analysts forecast an EPS of -0.49 USD, with revenue projected to reach -- USD, implying an decrease of -90.06% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ZOETIS INC.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.52
Actual
$1.75
Surprise
+14.64%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.38
Surprise
+1.04%
Guardian Pharmacy Services, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.30
Actual
$0.33
Surprise
+7.84%
Xeris Biopharma Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.06
Surprise
+144.90%
Cronos Group Inc. Common Share
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.03
Actual
$0.04
Surprise
+17.65%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.89
Actual
$1.96
Surprise
+3.17%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.32
Actual
$0.36
Surprise
+9.16%
ARS Pharmaceuticals, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.36
Surprise
-11.15%
Profound Medical Corp. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.21
Surprise
-11.41%
Akebia Therapeutics, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.03
Actual
-$0.04
Surprise
-6.95%
FAQ
What were Incannex Healthcare Limited Common Stock's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Incannex Healthcare Limited Common Stock reported EPS of -$4.93, missing estimates by -547.51%, and revenue of $0.00, 0% as expectations.
How did the market react to Incannex Healthcare Limited Common Stock's Q4 2026 earnings?
The stock price moved down -2.35%, changed from $3.40 before the earnings release to $3.32 the day after.
When is Incannex Healthcare Limited Common Stock expected to report next?
The next earning report is scheduled for Nov 12, 2026.
What are the forecasts for Incannex Healthcare Limited Common Stock's next earnings report?
Based on 3
analysts, Incannex Healthcare Limited Common Stock is expected to report EPS of -$0.49 and revenue of -- for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.